The import of antisera and other blood fractions into Brazil is forecasted to rise from 2024 to 2028, starting at 3.6385 million kilograms and reaching 3.7912 million kilograms. This data suggests a steady year-on-year growth rate: 2024 to 2025 sees a 1.08% increase, 2025 to 2026 shows a 1.05% rise, 2026 to 2027 indicates a 1.01% growth, and 2027 to 2028 projects a 0.99% increase. The compound annual growth rate (CAGR) over this five-year period is approximately 1.04%.
The trend reflects a consistent expansion in demand or need for these critical medical imports in Brazil. Future trends to watch for include the impact of technological advancements in biotech, changing healthcare policies, and economic factors affecting import relations. Keep an eye on how global health challenges and innovations could alter these projections.
